ENGAGE THERAPEUTICS Trademark

Trademark Overview

On Monday, April 6, 2015, a trademark application was filed for ENGAGE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ENGAGE THERAPEUTICS trademark a serial number of 86588727. The federal status of this trademark filing is REGISTERED as of Tuesday, January 15, 2019. This trademark is owned by Alexza Pharmaceuticals, Inc.. The ENGAGE THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the diagnosis and treatment of psychiatric disorders, neurological disorders, gastrointestinal disorders, and central nervous system disorders; pharmaceutical delivery devices in the nature of inhalers filled with drugs and diagnostic preparations for the detection and treatment of psychiatric disorders, neurological disorders, gastrointestinal disorders, and central nervous system disorders
engage therapeutics

General Information

Serial Number86588727
Word MarkENGAGE THERAPEUTICS
Filing DateMonday, April 6, 2015
Status700 - REGISTERED
Status DateTuesday, January 15, 2019
Registration Number5655985
Registration DateTuesday, January 15, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 29, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for the diagnosis and treatment of psychiatric disorders, neurological disorders, gastrointestinal disorders, and central nervous system disorders; pharmaceutical delivery devices in the nature of inhalers filled with drugs and diagnostic preparations for the detection and treatment of psychiatric disorders, neurological disorders, gastrointestinal disorders, and central nervous system disorders
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 15, 2015
Primary Code005
First Use Anywhere DateTuesday, April 17, 2018
First Use In Commerce DateTuesday, April 17, 2018

Trademark Owner History

Party NameENGAGE THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSUMMIT, NJ 07901
Party NameENGAGE THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSUMMIT, NJ 07901
Party NameAlexza Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMountain View, CA 94043
Party NameAlexza Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMountain View, CA 94043

Trademark Events

Event DateEvent Description
Thursday, April 11, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, April 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 11, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 11, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 11, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 11, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, January 15, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 15, 2019REGISTERED-PRINCIPAL REGISTER
Saturday, December 8, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, December 7, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, December 5, 2018STATEMENT OF USE PROCESSING COMPLETE
Friday, November 9, 2018USE AMENDMENT FILED
Friday, November 9, 2018TEAS STATEMENT OF USE RECEIVED
Saturday, May 26, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 25, 2018SOU EXTENSION 5 GRANTED
Thursday, May 24, 2018SOU EXTENSION 5 FILED
Thursday, May 24, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, November 22, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, November 9, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 7, 2017SOU EXTENSION 4 GRANTED
Tuesday, November 7, 2017SOU EXTENSION 4 FILED
Tuesday, November 7, 2017SOU TEAS EXTENSION RECEIVED
Friday, May 5, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 3, 2017SOU EXTENSION 3 GRANTED
Wednesday, May 3, 2017SOU EXTENSION 3 FILED
Wednesday, May 3, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, November 29, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 28, 2016SOU EXTENSION 2 GRANTED
Friday, November 11, 2016SOU EXTENSION 2 FILED
Monday, November 28, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 11, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, April 27, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 25, 2016SOU EXTENSION 1 GRANTED
Monday, April 25, 2016SOU EXTENSION 1 FILED
Monday, April 25, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, November 24, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 29, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 29, 2015PUBLISHED FOR OPPOSITION
Wednesday, September 9, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 26, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 26, 2015ASSIGNED TO LIE
Friday, August 7, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 21, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 20, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 20, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 16, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 16, 2015NON-FINAL ACTION E-MAILED
Thursday, July 16, 2015NON-FINAL ACTION WRITTEN
Monday, July 13, 2015ASSIGNED TO EXAMINER
Wednesday, April 15, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 9, 2015NEW APPLICATION ENTERED

Related Keywords

therapeutics engage disorders gastrointestinal central pharmaceutical system neurological nervous psychiatric preparations treatment